catechin and Angiogenesis, Pathologic

catechin has been researched along with Angiogenesis, Pathologic in 73 studies

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (2.74)18.2507
2000's30 (41.10)29.6817
2010's37 (50.68)24.3611
2020's4 (5.48)2.80

Authors

AuthorsStudies
Chen, X; Cheung, CW; Chung, JPW; Fung, LWY; Hung, SW; Li, TC; Man, GCW; Wang, CC; Zhang, T1
Mei, B; Sun, Q; Xiao, Q; Zhang, T; Zhang, X1
Chen, CY; Lan, SJ; Lan, YH; Lin, YJ; Sheu, MJ; Wang, CCN1
Han, DS; Lee, EO; Lee, HJ; Yeo, C1
Gallemit, PEM; Malaitad, T; Thongboonkerd, V; Yoodee, S1
Brandl, MB; Cirillo, G; Kavallaris, M; Kimpton, K; Kumar, N; Pasquier, E; Vittorio, O; Yee, EMH1
Chen, J; Dong, W; Fu, B; Li, M; Qian, M; Zeng, Q; Zhang, Z1
Chen, J; Chen, K; Dai, W; Fan, X; Feng, J; Guo, C; Ji, J; Li, J; Li, S; Liu, T; Mao, Y; Wang, C; Wang, F; Wu, J; Wu, L; Yu, Q; Zhang, J; Zhou, Y1
Kroon, PA; Moyle, CWA; Needs, PW; Perez-Moral, N1
Chen, J; Chen, Z; Di, L; Hu, L; Huang, J; Li, J; Qiao, H; Wang, H; Wang, R; Yang, M1
Dupertuis, YM; Lecumberri, E; Miralbell, R; Pichard, C1
Feng, X; Feng, Y; Li, X; Liu, J; Tang, X; Zhou, K1
Fukusato, T; Kubota, S; Muraguchi, T; Sakamoto, Y; Terashita, N1
Hashimoto, O; Hiroshi, M; Inoue, K; Iwamoto, H; Nakamura, A; Nakamura, T; Sata, M; Torimura, T; Ueno, T1
Hrabec, E; Hrabec, Z; Lewandowska, U; Owczarek, K; Podsędek, A; Sosnowska, D; Szewczyk, K1
Fukunaga, K; Maruyama, T; Murata, S; Nakayama, K; Nowatari, T; Nozaki, R; Ogawa, K; Ohkohchi, N; Sano, N; Tamura, T1
Feng, LL; Liu, BX; Sun, LB; Yu, HS; Zhong, JY1
Chen, HY; Chiang, AN; Guo, BC; Lee, TS; Shyue, SK; Su, KH; Wei, J; Zhao, JF1
Lin, B; Liu, F; Liu, X; Shi, J; Tang, X; Zhang, W1
Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M1
Chen, YC; Gao, Y; Rankin, GO; Tu, Y1
Ahmed, RS; Chan, TH; Dou, QP; El-Banna, HA; El-Ghoneimy, AA; Farshi, P; Foldes, R; Liu, G; Renzetti, A; Saed, G; Soave, C; Yang, H1
Li, QS; Liang, YR; Lu, JL; Polito, CA; Wang, A; Xiang, LP; Ye, JH; Zheng, XQ1
Dhatwalia, SK; Dhawan, DK; Kumar, M1
Wang, H; Yang, CS1
Battaglini, M; Berger, L; Cirillo, G; Dente, L; di Leo, N; Giannaccini, M; Hampel, S; Raffa, V; Vittorio, O1
McGeary, A; Penack, O; Rudloff, S; Westphal, S; Wilke, A1
Goodarzi, M; Malekzadeh, M; Masoudifar, A; Mirzaei, H; Rashidi, B1
Chan, TH; Chan, WK; Lam, WH; Lee, SC; Lee, TW; Wang, X; Wong, YC1
Greene, GL; Leong, H; Mathur, PS1
Chu, CY; Lui, WT; Ng, PS; Rogers, MS; Wang, CC; Xu, H1
Cai, SR; He, YL; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH1
Hida, K; Hida, Y; Matsuda, K; Muraki, C; Ohga, N; Ohiro, Y; Shindoh, M; Totsuka, Y; Tsuchiya, K1
Baron, ED; Camouse, MM; Cooper, KD; Domingo, DS; Hsia, AH; Maes, D; Matsui, M; Ward, NL1
Asakawa, T; Kan, T; Oku, N; Piyaviriyakul, S; Shimizu, K; Siripong, P1
Shi, X; Xu, W; Yao, H; Zhang, Z1
Banik, NL; Karmakar, S; Mohan, N; Ray, SK1
Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Braicu, C; Gherman, C; Irimie, F; Rus, M; Soritau, O; Tudoran, O; Virag, P1
Horikawa, K; Matsubara, K; Mizushina, Y; Nakajima, N; Saito, A; Tanaka, A; Yoshida, H1
Becker, CM; Birsner, AE; Chu, CY; D'Amato, RJ; Davis, TN; Kung, AL; Lui, WT; Wai Man, GC; Wang, CC; Xu, H1
Wu, H; Xiao, Y; Xin, Y; Zhao, J1
Banik, NL; Hossain, MM; Ray, SK1
Chan, TH; Cheng, JT; Chu, CY; Chu, KO; He, YX; Kwong, J; Lau, TS; Li, G; Man, GC; Qin, L; Wang, CC; Xu, H; Zhang, T1
Marsh, L; Shankar, S; Srivastava, RK1
Barañao, RI; Bastón, JI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG; Singla, JJ1
He, L; Le, AD; Li, X; Shi, J; Tang, X; Zhang, E; Zhang, Q; Zhou, K1
Beatty, P; Brooks, MN; Elashoff, D; Elashoff, R; Go, VL; Heber, D; Sartippour, MR; Zhang, L1
Albini, A; Benelli, R; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M1
Meydani, M; Nguyen, N; Tang, FY1
Hitsuda, Y; Igishi, T; Kodani, M; Matsumoto, S; Nakanishi, H; Shigeoka, Y; Shimizu, E; Yasuda, K1
Gouni-Berthold, I; Sachinidis, A1
Akizawa, T; Asai, T; Matsukawa, M; Oku, N; Uchida, T; Yamakawa, S1
Albini, A; Benelli, R; Fassina, G; Minghelli, S; Morini, M; Noonan, DM; Venè, R1
Chao, WT; Chen, YT; Lai, HC; Yang, VC1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Dulak, J1
Band, MA; Guo, W; Liu, L; Meydani, M; Paulson, EK; Rodriguez, SK1
Adhami, VM; Mukhtar, H; Saleem, M; Siddiqui, IA1
Afaq, F; Ahmad, N; Khan, N; Mukhtar, H; Saleem, M1
Bayer, DK; Beltz, LA; Moss, AL; Simet, IM1
Chiang, EP; Shih, CJ; Tang, FY1
Blumberg, JB; Boucher, Y; Eisenberg, DM; Held, KD; Jain, RK; Kashiwagi, S; Lawenda, BD; Loeffler, JS; Niemierko, A; Silverstein, JR; Smith, DE; Xu, L1
Biggin, S; Caniato, R; Dell'Aica, I; Garbisa, S1
Cai, SR; He, YL; Li, ZR; Ma, JP; Peng, JS; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH1
Ganapathy, S; Shankar, S; Srivastava, RK1
Buxton, IL; Javed, MA; Law, WE; Rumjahn, SM; Wong, N1
Ganapathy, S; Hingorani, SR; Shankar, S; Srivastava, RK1
Adhami, VM; Asim, M; Hafeez, BB; Malik, A; Mukhtar, H; Sarfaraz, S; Siddiqui, IA1
Hsiao, TY; Kok, SH; Lin, SK; Liu, CM; Shun, CT; Wang, CC1
Cao, R; Cao, Y1
L'Allemain, G1
Albini, A; De Flora, S; Ferrari, N; Tosetti, F1
Ellis, LM; Jung, YD1

Reviews

16 review(s) available for catechin and Angiogenesis, Pathologic

ArticleYear
Therapeutic effects of green tea on endometriosis.
    Critical reviews in food science and nutrition, 2023, Volume: 63, Issue:18

    Topics: Apoptosis; Catechin; Endometriosis; Female; Humans; Neovascularization, Pathologic; Tea

2023
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Clinical nutrition (Edinburgh, Scotland), 2013, Volume: 32, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Cycle; Chemotherapy, Adjuvant; Humans; Neoplasms; Neovascularization, Pathologic; Polyphenols; Tea

2013
Suppressive Effects of Tea Catechins on Breast Cancer.
    Nutrients, 2016, Jul-28, Volume: 8, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Camellia sinensis; Catechin; Dietary Supplements; Evidence-Based Medicine; Female; Food Handling; Functional Food; Gallic Acid; Humans; Intestinal Absorption; Neovascularization, Pathologic; Oxidation-Reduction; Plant Extracts; Plant Leaves; Reproducibility of Results; Risk; Tea

2016
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:11

    Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Artemisinins; Catechin; Cell Proliferation; Curcumin; Humans; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Resveratrol; Stilbenes; Triterpenes

2016
Cancer Preventive Activities of Tea Catechins.
    Molecules (Basel, Switzerland), 2016, Dec-09, Volume: 21, Issue:12

    Topics: Animals; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Neoplasms; Neovascularization, Pathologic; Tea

2016
Green tea and its anti-angiogenesis effects.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 89

    Topics: Animals; Catechin; Humans; MicroRNAs; Neovascularization, Pathologic; Tea; Vascular Endothelial Growth Factors

2017
Dietary flavonoids as cancer prevention agents.
    Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews, 2011, Volume: 29, Issue:1

    Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Curcumin; Diet; Flavonoids; Food; Humans; Isothiocyanates; Neovascularization, Pathologic; Signal Transduction

2011
Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases.
    Current pharmaceutical design, 2004, Volume: 10, Issue:11

    Topics: Animals; Apoptosis; Camellia sinensis; Catechin; Coronary Artery Disease; Growth Substances; Humans; Neoplasms; Neovascularization, Pathologic; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tea

2004
Nutraceuticals as anti-angiogenic agents: hopes and reality.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2005, Volume: 56 Suppl 1

    Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Catechin; Curcumin; Dietary Supplements; Flavonoids; Humans; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A

2005
Beneficial effects of tea and its polyphenols against prostate cancer.
    Molecular nutrition & food research, 2006, Volume: 50, Issue:2

    Topics: Androgens; Animals; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; Fermentation; Flavonoids; Gene Expression; Humans; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Phenols; Polyamines; Polyphenols; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Tea

2006
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Cancer research, 2006, Mar-01, Volume: 66, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; ErbB Receptors; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; NF-kappa B; Protease Inhibitors; Receptor, IGF Type 1; Signal Transduction; Tea; Vascular Endothelial Growth Factor A

2006
Mechanisms of cancer prevention by green and black tea polyphenols.
    Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:5

    Topics: Animals; Antioxidants; Apoptosis; Arachidonic Acid; Catechin; Cell Cycle; Cell Proliferation; fas Receptor; Flavonoids; Gene Expression; Humans; Lipid Peroxidation; Lipoproteins, LDL; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide; Oncogenes; Oxidation-Reduction; Phenols; Polyphenols; Proteasome Inhibitors; Reactive Oxygen Species; Receptors, Androgen; Receptors, Aryl Hydrocarbon; Receptors, Growth Factor; Tea; Telomere; Tetrahydrofolate Dehydrogenase

2006
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
    Clinica chimica acta; international journal of clinical chemistry, 2007, Volume: 381, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Bridged Bicyclo Compounds; Catechin; Humans; Hypericum; Matrix Metalloproteinases; Neovascularization, Pathologic; Phloroglucinol; Pulmonary Fibrosis; Tea; Terpenes

2007
Green tea polyphenols: biology and therapeutic implications in cancer.
    Frontiers in bioscience : a journal and virtual library, 2007, Sep-01, Volume: 12

    Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Proliferation; Flavonoids; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Signal Transduction; Tea

2007
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:1

    Topics: Acetylcysteine; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Catechin; Flavonoids; Humans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Protease Inhibitors; Receptors, Cytoplasmic and Nuclear

2002
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    International journal of experimental pathology, 2001, Volume: 82, Issue:6

    Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Catechin; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phytotherapy; Plant Extracts; Tea

2001

Trials

1 trial(s) available for catechin and Angiogenesis, Pathologic

ArticleYear
Anti-angiogenic effects of epigallocatechin-3-gallate in human skin.
    International journal of clinical and experimental pathology, 2010, Aug-05, Volume: 3, Issue:7

    Topics: Administration, Cutaneous; Adult; Angiogenesis Inhibitors; Catechin; Dosage Forms; Double-Blind Method; Erythema; Face; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Middle Aged; Neovascularization, Pathologic; Skin; Telangiectasis; Vascular Endothelial Growth Factor A

2010

Other Studies

56 other study(ies) available for catechin and Angiogenesis, Pathologic

ArticleYear
Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
    Bioengineered, 2022, Volume: 13, Issue:3

    Topics: Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Neovascularization, Pathologic; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2022
Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 120

    Topics: Angiogenesis Inhibitors; Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Endoglin; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyrroles; Signal Transduction; Smad1 Protein; Vascular Endothelial Growth Factor A

2019
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    International journal of molecular sciences, 2020, Jan-09, Volume: 21, Issue:2

    Topics: Antigens, CD; Cadherins; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Male; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Twist-Related Protein 1

2020
Epigallocatechin-3-gallate plays more predominant roles than caffeine for inducing actin-crosslinking, ubiquitin/proteasome activity and glycolysis, and suppressing angiogenesis features of human endothelial cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141

    Topics: Angiogenesis Inhibitors; Caffeine; Catechin; Cell Line, Tumor; Cell Proliferation; Coffee; Cross-Linking Reagents; Endothelial Cells; Endothelium, Vascular; Glycolysis; Humans; Matrix Metalloproteinase 2; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Tea; Ubiquitin; Ubiquitination

2021
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells.
    Scientific reports, 2017, 08-09, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Catechin; Cation Transport Proteins; Cell Survival; Cells, Cultured; Copper; Copper Transport Proteins; Copper Transporter 1; Dextrans; Disease Models, Animal; Endothelial Cells; Heterografts; Homeostasis; Humans; Metallochaperones; Molecular Chaperones; Neoplasm Transplantation; Neovascularization, Pathologic; Neuroblastoma; Reactive Oxygen Species; Trace Elements; Treatment Outcome

2017
Epicatechin Gallate Protects HBMVECs from Ischemia/Reperfusion Injury through Ameliorating Apoptosis and Autophagy and Promoting Neovascularization.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Antioxidants; Apoptosis; Autophagy; Catechin; Humans; Neovascularization, Pathologic; Reperfusion Injury; Stroke; Tea

2019
Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:9

    Topics: Animals; Biflavonoids; Carbon Tetrachloride; Catechin; Cell Line; Cell Proliferation; Down-Regulation; Hedgehog Proteins; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Morphogenesis; Neovascularization, Pathologic; Proanthocyanidins; Signal Transduction; Transforming Growth Factor beta1; Veratrum Alkaloids

2019
Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors.
    Molecules (Basel, Switzerland), 2019, Jul-31, Volume: 24, Issue:15

    Topics: Catechin; Cell Proliferation; Circular Dichroism; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Neovascularization, Pathologic; Polyphenols; Protein Binding; Protein Structure, Secondary; Signal Transduction; Surface Plasmon Resonance; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2019
Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles.
    Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 21

    Topics: Animals; Apoptosis; Catechin; Colonic Neoplasms; Fluorouracil; HT29 Cells; Humans; Mice; Nanoconjugates; Neovascularization, Pathologic; Wheat Germ Agglutinins; Xenograft Model Antitumor Assays

2019
Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.
    Journal of nutrigenetics and nutrigenomics, 2013, Volume: 6, Issue:3

    Topics: Base Sequence; Catechin; Cell Line, Tumor; DNA Primers; Down-Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Lung Neoplasms; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A

2013
Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis.
    Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:9

    Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endostatins; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2013
Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.
    Nutrition and cancer, 2014, Volume: 66, Issue:4

    Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014
Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis.
    Nutrition and cancer, 2013, Volume: 65, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoprevention; Female; Humans; Ki-67 Antigen; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Oenothera; Plant Extracts; Proanthocyanidins; Proto-Oncogene Proteins c-fos; RNA, Messenger; Seeds; Vascular Endothelial Growth Factor A

2013
(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer.
    Oncology reports, 2014, Volume: 31, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Enzyme Activation; HCT116 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, SCID; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor Receptor-2

2014
Effect of grape procyanidins on tumor angiogenesis in liver cancer xenograft models.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:2

    Topics: Animals; Antioxidants; Biflavonoids; Carcinoma, Hepatocellular; Catechin; Humans; Immunoenzyme Techniques; Liver Neoplasms; Mice; Neovascularization, Pathologic; Phytotherapy; Proanthocyanidins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vitis; Xenograft Model Antitumor Assays

2014
Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.
    Molecular nutrition & food research, 2015, Volume: 59, Issue:4

    Topics: AMP-Activated Protein Kinases; Anilides; Animals; Calcium; Capsaicin; Catechin; Cell Movement; Cell Proliferation; Cell Survival; Cinnamates; Endothelial Cells; HEK293 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Tea; TRPV Cation Channels

2015
Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells.
    Oncology reports, 2015, Volume: 33, Issue:6

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Nicotine; Smoking; Tea; Xenograft Model Antitumor Assays

2015
PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Cell Count; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Flow Cytometry; Humans; Kinetics; Lactic Acid; Mice; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyphenols; Reactive Oxygen Species; Tea

2015
Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
    International journal of oncology, 2016, Volume: 48, Issue:1

    Topics: Biflavonoids; Carcinoma; Catechin; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Oncogene Protein v-akt; Ovarian Neoplasms; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Signal Transduction; Vascular Endothelial Growth Factor A

2016
Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
    Journal of cellular biochemistry, 2016, Volume: 117, Issue:10

    Topics: Apoptosis; Blotting, Western; Catechin; Cell Movement; Cell Proliferation; Female; Fluorescent Antibody Technique; Humans; Leiomyoma; Neovascularization, Pathologic; Prodrugs; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Uterine Neoplasms

2016
A catechin nanoformulation inhibits WM266 melanoma cell proliferation, migration and associated neo-angiogenesis.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017, Volume: 114

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Compounding; Humans; Melanoma; Nanoparticles; Neovascularization, Pathologic; Xenograft Model Antitumor Assays; Zebrafish

2017
The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Alkaloids; Allografts; Animals; Antioxidants; Benzodioxoles; Catechin; Disease Models, Animal; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Quercetin; T-Lymphocytes, Regulatory; Tea

2017
Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Nutrition and cancer, 2008, Volume: 60, Issue:4

    Topics: Acetates; Androgens; Animals; Apoptosis; Biological Availability; Catechin; Cell Division; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Prodrugs; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Transplantation, Heterologous

2008
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.
    Breast cancer research and treatment, 2009, Volume: 117, Issue:3

    Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Endothelial Cells; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Gene Expression Regulation; Humans; Immunohistochemistry; Immunoprecipitation; Interferon-gamma; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Tea; Transfection; Vascular Endothelial Growth Factor A

2009
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
    Human reproduction (Oxford, England), 2009, Volume: 24, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Catechin; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Mice; Mice, SCID; Microcirculation; Neovascularization, Pathologic; Tea; Vitamin E

2009
[Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2009, Volume: 12, Issue:1

    Topics: Animals; Catechin; Cell Line, Tumor; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2009
Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Cancer science, 2009, Volume: 100, Issue:10

    Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Catechin; Cell Line, Tumor; Cell Movement; Down-Regulation; Endothelial Cells; Flavonoids; Flow Cytometry; Gene Expression; Humans; Matrix Metalloproteinase 9; Melanoma; Mice; Microvessels; Neovascularization, Pathologic; Phenols; Polyphenols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Tea; Xenograft Model Antitumor Assays

2009
Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:3

    Topics: Actins; Angiogenesis Inhibitors; Biological Transport; Camellia sinensis; Catechin; Cell Line; Cell Movement; Cell Proliferation; Cytoplasm; Endothelial Cells; Endothelium, Vascular; Humans; Mitochondria; Neovascularization, Pathologic; Plant Extracts

2011
SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.
    Neurochemical research, 2011, Volume: 36, Issue:8

    Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; E2F1 Transcription Factor; Humans; In Situ Nick-End Labeling; Indoles; Neovascularization, Pathologic; Neuroblastoma; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Retinoblastoma Protein; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2011
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:3

    Topics: Angiogenesis Inhibitors; Apoptosis; Catechin; Cell Adhesion; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Neoplasm Invasiveness; Neovascularization, Pathologic; Proteoglycans; Signal Transduction; Transcription, Genetic; Uterine Cervical Neoplasms

2012
Acylated catechin derivatives: inhibitors of DNA polymerase and angiogenesis.
    Frontiers in bioscience (Elite edition), 2011, 06-01, Volume: 3, Issue:4

    Topics: Acylation; Animals; Catechin; Enzyme Inhibitors; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Wistar

2011
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
    Fertility and sterility, 2011, Volume: 96, Issue:4

    Topics: Adult; Animals; Catechin; Cells, Cultured; Endometriosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Random Allocation; Signal Transduction; Tea; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-2

2011
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012
Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
    Experimental cell research, 2012, Aug-01, Volume: 318, Issue:13

    Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Caspases; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Movement; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Neovascularization, Pathologic; Neuroblastoma; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Survivin

2012
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Angiogenesis, 2013, Volume: 16, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Availability; Catechin; Endometriosis; Endometrium; Female; Mice; Neovascularization, Pathologic; Ovarian Follicle; Oxidation-Reduction; Prodrugs; Tea

2013
EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
    Molecular and cellular biochemistry, 2013, Volume: 372, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Catechin; Cell Line, Tumor; Cell Proliferation; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neuropilins; Pancreas; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Tumor Burden; Xenograft Model Antitumor Assays

2013
Natural therapies assessment for the treatment of endometriosis.
    Human reproduction (Oxford, England), 2013, Volume: 28, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Injections, Intraperitoneal; Intestinal Diseases; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Resveratrol; Stilbenes

2013
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Human papillomavirus 16; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oncogene Proteins; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Repressor Proteins; Signal Transduction; Transfection; Vascular Endothelial Growth Factor A

2013
Inhibition of fibroblast growth factors by green tea.
    International journal of oncology, 2002, Volume: 21, Issue:3

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Breast Neoplasms; Catechin; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Humans; Neovascularization, Pathologic; Plant Extracts; RNA, Messenger; Tea

2002
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.
    Journal of immunology (Baltimore, Md. : 1950), 2003, Apr-15, Volume: 170, Issue:8

    Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Catechin; Collagen; Drug Combinations; Fluorescein-5-isothiocyanate; Humans; Injections, Subcutaneous; Laminin; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neovascularization, Pathologic; Neutrophil Activation; Neutrophil Infiltration; Neutrophils; Oxidants; Plant Extracts; Proteoglycans; Pulmonary Fibrosis; Tea

2003
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
    International journal of cancer, 2003, Oct-10, Volume: 106, Issue:6

    Topics: Angiogenesis Inhibitors; Antigens, CD; Antineoplastic Agents; Blotting, Western; Cadherins; Catechin; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; Lasers; Neovascularization, Pathologic; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tea; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2003
Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
    Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Caffeic Acids; Catechin; Cell Movement; Curcumin; Humans; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenylethyl Alcohol; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sulindac; Transforming Growth Factor beta; Tumor Cells, Cultured

2004
(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
    Cancer letters, 2004, Jul-08, Volume: 210, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Cell Movement; Colonic Neoplasms; Endothelium, Vascular; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Methylcholanthrene; Mice; Neovascularization, Pathologic; Sarcoma, Experimental; Tumor Cells, Cultured; Umbilical Veins; Urokinase-Type Plasminogen Activator

2004
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-15, Volume: 10, Issue:14

    Topics: Animals; Apoptosis; Capillaries; Catechin; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; NIH 3T3 Cells; Plant Preparations; Sarcoma, Kaposi; Tea; Vascular Neoplasms; Xenograft Model Antitumor Assays

2004
Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro.
    Cancer letters, 2004, Sep-30, Volume: 213, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Aorta; Blotting, Western; Catechin; Cell Culture Techniques; Cell Division; Collagen; Culture Media; Down-Regulation; Endothelial Cells; Morphogenesis; Neovascularization, Pathologic; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Transcription Factors; Umbilical Veins

2004
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Oncology reports, 2005, Volume: 13, Issue:2

    Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
    International journal of cancer, 2006, Apr-01, Volume: 118, Issue:7

    Topics: Catechin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; Tea; Umbilical Veins; Vascular Endothelial Growth Factor A

2006
Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
    The Journal of nutritional biochemistry, 2007, Volume: 18, Issue:6

    Topics: Catechin; Cell Movement; Endothelium, Vascular; Ephrin-A1; Ephrin-A2; Humans; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Recombinant Proteins; Tea; Umbilical Veins

2007
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma.
    Journal of the Society for Integrative Oncology, 2007,Winter, Volume: 5, Issue:1

    Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dietary Supplements; Female; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Pilot Projects; Radiation-Protective Agents; Vitamin E

2007
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    World journal of gastroenterology, 2007, Feb-28, Volume: 13, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2007
Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase.
    British journal of cancer, 2007, Nov-19, Volume: 97, Issue:10

    Topics: Adenosine Triphosphate; Breast Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Ellagic Acid; Endothelial Cells; Humans; Neovascularization, Pathologic; Nucleoside-Diphosphate Kinase; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Tumor Cells, Cultured

2007
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
    Frontiers in bioscience : a journal and virtual library, 2008, Jan-01, Volume: 13

    Topics: Animals; Catechin; Cell Proliferation; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms

2008
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Oncogene, 2008, Mar-27, Volume: 27, Issue:14

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2008
Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
    Archives of otolaryngology--head & neck surgery, 2008, Volume: 134, Issue:5

    Topics: Antioxidants; Camellia sinensis; Catechin; Cell Hypoxia; Cells, Cultured; Cobalt; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Nasal Polyps; Neovascularization, Pathologic; Plant Extracts; Vascular Endothelial Growth Factor A

2008
Angiogenesis inhibited by drinking tea.
    Nature, 1999, Apr-01, Volume: 398, Issue:6726

    Topics: Animals; Catechin; Cattle; Corneal Neovascularization; Drinking; Endothelium, Vascular; Mice; Neovascularization, Pathologic; Rats; Tea; Tumor Cells, Cultured

1999
[Multiple actions of EGCG, the main component of green tea].
    Bulletin du cancer, 1999, Volume: 86, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Humans; Neovascularization, Pathologic; Tea

1999